US28036F1057
US28036F1057
Edgewise Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 191.406.000 | 158.832.000 | 20.5% | |
| Operating Income | -191.406.000 | -158.832.000 | 20.5% |
| Pretax Income | -167.795.000 | -133.813.000 | 25.4% |
| Net Income Common Stockholders | -167.795.000 | -133.813.000 | 25.4% |
| -- | -- | -- | |
| -- | -- | -- |